5 5 Chelston Chiropody Limited 05415594 false 2024-11-01 2025-10-31 2025-10-31 The principal activity of the company is chiropody Digita Accounts Production Advanced 6.30.9574.0 true true 05415594 2024-11-01 2025-10-31 05415594 2025-10-31 05415594 bus:Director2 1 2025-10-31 05415594 bus:OrdinaryShareClass1 2025-10-31 05415594 core:CurrentFinancialInstruments 2025-10-31 05415594 core:CurrentFinancialInstruments core:WithinOneYear 2025-10-31 05415594 core:FurnitureFittingsToolsEquipment 2025-10-31 05415594 bus:SmallEntities 2024-11-01 2025-10-31 05415594 bus:AuditExemptWithAccountantsReport 2024-11-01 2025-10-31 05415594 bus:FilletedAccounts 2024-11-01 2025-10-31 05415594 bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 05415594 bus:RegisteredOffice 2024-11-01 2025-10-31 05415594 bus:Director2 2024-11-01 2025-10-31 05415594 bus:Director2 1 2024-11-01 2025-10-31 05415594 bus:OrdinaryShareClass1 2024-11-01 2025-10-31 05415594 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 05415594 bus:Agent1 2024-11-01 2025-10-31 05415594 core:FurnitureFittingsToolsEquipment 2024-11-01 2025-10-31 05415594 core:ToolsEquipment 2024-11-01 2025-10-31 05415594 countries:EnglandWales 2024-11-01 2025-10-31 05415594 2024-10-31 05415594 bus:Director2 1 2024-10-31 05415594 core:FurnitureFittingsToolsEquipment 2024-10-31 05415594 2023-11-01 2024-10-31 05415594 2024-10-31 05415594 bus:Director2 1 2024-10-31 05415594 bus:OrdinaryShareClass1 2024-10-31 05415594 core:CurrentFinancialInstruments 2024-10-31 05415594 core:CurrentFinancialInstruments core:WithinOneYear 2024-10-31 05415594 core:FurnitureFittingsToolsEquipment 2024-10-31 05415594 bus:Director2 1 2023-11-01 2024-10-31 05415594 bus:Director2 1 2023-10-31 xbrli:pure iso4217:GBP xbrli:shares

Registration number: 05415594

Chelston Chiropody Limited
Unaudited Filleted Financial Statements
for the Year Ended 31 October 2025

Chelston Chiropody Limited

Contents

Company Information | 1
Balance Sheet | 2
Notes to the Unaudited Financial Statements | 3 to 8

Chelston Chiropody Limited

Company Information

Director | Mrs Julia Caulfield

Registered office | 32a Walnut Road Chelston Torquay Devon TQ2 6HS

Accountants | Neil Wilson & Co Chartered Accountants Bank Chambers 260-262 Union Street Torquay Devon TQ2 5QU

Chelston Chiropody Limited

(Registration number: 05415594)
Balance Sheet as at 31 October 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets | 4 | 6,694 | 758
Current assets |  |  |
Stocks | 5 | 1,850 | 1,550
Debtors | 6 | 5,190 | 11,225
Cash at bank and in hand |  | 5,073 | 2,612
|  | 12,113 | 15,387
Creditors: Amounts falling due within one year | 7 | (10,453) | (15,734)
Net current assets/(liabilities) |  | 1,660 | (347)
Net assets |  | 8,354 | 411
Capital and reserves |  |  |
Called up share capital | 8 | 3 | 3
Retained earnings |  | 8,351 | 408
Shareholders' funds |  | 8,354 | 411

For the financial year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 23 February 2026

......................................... Mrs Julia Caulfield Director

Chelston Chiropody Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
32a Walnut Road
Chelston
Torquay
Devon
TQ2 6HS
England

These financial statements were authorised for issue by the director on 23 February 2026.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Chelston Chiropody Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Equipment | 15% Reducing balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.
The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Chelston Chiropody Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.
Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.
Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.
Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was 5 (2024 - 5).

Chelston Chiropody Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

4 | Tangible assets

| Furniture, fittings and equipment £ | Total £
Cost or valuation
At 1 November 2024 | 10,749 | 10,749
Additions | 8,168 | 8,168
At 31 October 2025 | 18,917 | 18,917
Depreciation
At 1 November 2024 | 9,991 | 9,991
Charge for the year | 2,232 | 2,232
At 31 October 2025 | 12,223 | 12,223
Carrying amount
At 31 October 2025 | 6,694 | 6,694
At 31 October 2024 | 758 | 758

5 | Stocks

| 2025 £ | 2024 £
Other inventories | 1,850 | 1,550

6 | Debtors

Current | 2025 £ | 2024 £
Trade debtors | - | 17
Other debtors | 5,190 | 11,208
| 5,190 | 11,225

7 | Creditors

Creditors: amounts falling due within one year

Chelston Chiropody Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

| Note | 2025 £ | 2024 £
Due within one year |  |  |
Loans and borrowings | 9 | 4,131 | 11,453
Taxation and social security |  | 5,397 | 3,356
Accruals and deferred income |  | 925 | 925
|  | 10,453 | 15,734

8 | Share capital

Allotted, called up and fully paid shares

| 2025 | 2024
| No. | £ | No. | £
Ordinary of £1 each | 3 | 3 | 3 | 3

9 | Loans and borrowings

Current loans and borrowings

| 2025 £ | 2024 £
Bank borrowings | 4,131 | 11,453

10 | Dividends

|  | 2025 |  | 2024
|  | £ |  | £
Interim dividend of £7,000.00 (2024 - £4,667.00) per ordinary share |  | 21,000 |  | 14,000

11 | Related party transactions

Transactions with the director

2025 | At 1 November 2024 £ | Repayments by director £ | At 31 October 2025 £
Mrs Julia Caulfield
Director loan | 11,208 | 6,018 | 17,226

Chelston Chiropody Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

2024 | At 1 November 2023 £ | Advances to director £ | Repayments by director £ | At 31 October 2024 £
Mrs Julia Caulfield
Director loan | 27,136 | 6,000 | (21,928) | 11,208

Director's remuneration

The director's remuneration for the year was as follows:

| 2025 £ | 2024 £
Remuneration | 12,570 | 12,570
Compensation for loss of office | - | 8,400
| 12,570 | 20,970

Dividends paid to the director

|  | 2025 £ |  | 2024 £
Mrs Julia Caulfield |  |  |  |
Interim dividend paid |  | 21,000 |  | 10,000